Cellics
Cellics Therapeutics is a preclinical stage company, developing therapies for various diseases using cell membrane coating technology. The company's proprietary Nanosponge Technology is based on coating nanoparticles and nanomaterials with cellular membranes taken directly from cells. The company focuses on the development of red blood cell membrane (RBC) coated Nanosponges to develop therapies for infectious…
Funding snapshot
About
Cellics Therapeutics is a preclinical stage company, developing therapies for various diseases using cell membrane coating technology. The company's proprietary Nanosponge Technology is based on coating nanoparticles and nanomaterials with cellular membranes taken directly from cells. The company focuses on the development of red blood cell membrane (RBC) coated Nanosponges to develop therapies for infectious diseases, autoimmune disorders, anti-venom, and vaccines. The company claims that the n Founded in 2014, headquartered in San Diego, United States. The company has raised $26M at the Series B stage backed by investors including CARB-X, Cash Capital. Operating in Life Sciences > Drug Delivery, High Tech > Nanotechnology.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drugs,
Drug Delivery > Diversified
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.